{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:05:21Z","timestamp":1771020321980,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>RYR1-related congenital myopathies are rare disorders that severely impair muscle function and the quality of life of patients and their families. To date no pharmacological therapies are available to treat the severe muscle weakness of affected patients. The most severe forms of RYR1-related congenital myopathies are caused by compound heterozygous mutations (nonsense\/frameshift in one allele and a missense mutation in the other), leading to reduced RyR1 protein levels and altered biochemical composition of muscles. In this pre-clinical study, we treated a mouse model carrying the RyR1 p.Q1970fsX16\u2009+\u2009p.A4329D compound heterozygous pathogenic variants (dHT mice) for 15\u00a0weeks with 0.05\u00a0mg\/kg 5-aza-2\u2032-deoxycytidine, an FDA-approved drug targeting DNA methyltransferases. We evaluated muscle strength, calcium homeostasis and muscle proteome and report that drug treatment improves all investigated parameters in dHT mice. Importantly, the beneficial effects were particularly significant in fast twitch muscles which are the first muscles to be impaired in patients. In conclusion, this study provides proof of concept for the pharmacological treatment of patients with recessive RYR1-related congenital myopathies with the FDA approved 5-aza-2\u2032-deoxycytidine, supporting its use in a phase 1\/2 clinical trial.<\/jats:p>","DOI":"10.1093\/hmg\/ddaf021","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:26:30Z","timestamp":1738355190000},"page":"790-805","source":"Crossref","is-referenced-by-count":2,"title":["5-aza-2-deoxycytidine improves skeletal muscle function in a mouse model for recessive <i>RYR1<\/i>-related congenital myopathy"],"prefix":"10.1093","volume":"34","author":[{"given":"Alexis","family":"Ruiz","sequence":"first","affiliation":[{"name":"Neuromuscular Research Group, Departments of Neurology and Biomedicine, Basel University Hospital , Hebelstrasse 20, 4031 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Noreen","sequence":"additional","affiliation":[{"name":"Genome plasticity group, Department of Biomedicine, University of Basel , Mattenstrasse 28 4058, Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Meier","sequence":"additional","affiliation":[{"name":"Neuromuscular Research Group, Departments of Neurology and Biomedicine, Basel University Hospital , Hebelstrasse 20, 4031 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Buczak","sequence":"additional","affiliation":[{"name":"Proteomics Core Facility, Biozentrum, University of Basel , Spitalstrasse 41 4056 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Zorzato","sequence":"additional","affiliation":[{"name":"Neuromuscular Research Group, Departments of Neurology and Biomedicine, Basel University Hospital , Hebelstrasse 20, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Life Science and Biotechnology, University of Ferrara , Via Borsari 46, 44121 Ferrara ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-9631","authenticated-orcid":false,"given":"Susan","family":"Treves","sequence":"additional","affiliation":[{"name":"Neuromuscular Research Group, Departments of Neurology and Biomedicine, Basel University Hospital , Hebelstrasse 20, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Life Science and Biotechnology, University of Ferrara , Via Borsari 46, 44121 Ferrara ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2025042106064845100_ref1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1152\/physrev.1977.57.1.71","article-title":"Calcium release from the sarcoplasmic reticulum","volume":"57","author":"Endo","year":"1977","journal-title":"Physiol Rev"},{"key":"2025042106064845100_ref2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.bb.18.060189.002001","article-title":"Biochemistry and biophysics of excitation contraction coupling","volume":"18","author":"Fleischer","year":"1988","journal-title":"Annu Rev Biophys Biophys Chem"},{"key":"2025042106064845100_ref3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/physrev.1991.71.3.849","article-title":"Voltage sensor of excitation-contraction coupling in skeletal muscle","volume":"71","author":"Rios","year":"1991","journal-title":"Physiol Rev"},{"key":"2025042106064845100_ref4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"2025042106064845100_ref5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric United States population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann Neurol"},{"key":"2025042106064845100_ref6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"2025042106064845100_ref7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1750-1172-8-117","article-title":"Genotype-phenotype correlations in recessive RYR1-related myopathies","volume":"8","author":"Amburgey","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2025042106064845100_ref8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","article-title":"Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene- associated myopathies","volume":"33","author":"Klein","year":"2012","journal-title":"Hum Mutat"},{"key":"2025042106064845100_ref9","doi-asserted-by":"crossref","first-page":"e1495","DOI":"10.1212\/WNL.0000000000207723","article-title":"Long-term natural history of pediatric dominant and recessive RYR1-related myopathy","volume":"101","author":"Sarkozy","year":"2023","journal-title":"Neurology"},{"key":"2025042106064845100_ref10","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddz092","article-title":"Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16+A4329D cause cores and loss of muscle strength","volume":"29","author":"Elbaz","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2025042106064845100_ref11","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/hmg\/ddz025","article-title":"Quantitative reduction of RyR1 protein caused by a single-allele frameshift mutation in RYR1 ex36 impairs the strength of adult skeletal muscle fibres","volume":"28","author":"Elbaz","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2025042106064845100_ref12","doi-asserted-by":"crossref","first-page":"e83618","DOI":"10.7554\/eLife.83618","article-title":"Quantitative proteomic analysis of skeletal muscles from wild type and transgenic mice carrying recessive Ryr1 mutations linked to congenital myopathies","volume":"12","author":"Eckhardt","year":"2023","journal-title":"elife"},{"key":"2025042106064845100_ref13","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1093\/hmg\/ddv195","article-title":"Epigenetic changes as a common trigger of muscle weakness in congenital myopathies","volume":"24","author":"Rokach","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2025042106064845100_ref14","doi-asserted-by":"crossref","first-page":"fcac224","DOI":"10.1093\/braincomms\/fcac224","article-title":"Targeted transcript analysis in muscles from patients with genetically diverse congenital myopathies","volume":"4","author":"Bachmann","year":"2022","journal-title":"Brain Commun"},{"key":"2025042106064845100_ref15","first-page":"962","article-title":"Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies","volume":"40","author":"Bachmann","year":"2019","journal-title":"Hum Mutat"},{"key":"2025042106064845100_ref16","first-page":"405","article-title":"Acute exercise remodels promoter methylation in human skeletal muscle","volume":"7","author":"Barr\u00e8s","year":"2015","journal-title":"Cell Metab"},{"key":"2025042106064845100_ref17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00401-020-02150-w","article-title":"Intracellular calcium leak as a therapeutic target for RYR1-related myopathies","volume":"139","author":"Kushnir","year":"2020","journal-title":"Acta Neuropathol"},{"key":"2025042106064845100_ref18","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1212\/WNL.0000000000008872","article-title":"Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies","volume":"94","author":"Todd","year":"2020","journal-title":"Neurology"},{"key":"2025042106064845100_ref19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/cells13010031","article-title":"Successful correction by prime editing of a mutation in the RYR1 gene responsible for a myopathy","volume":"13","author":"Godbout","year":"2023","journal-title":"Cells"},{"key":"2025042106064845100_ref20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"2025042106064845100_ref21","doi-asserted-by":"crossref","first-page":"e73718","DOI":"10.7554\/eLife.73718","article-title":"Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors","volume":"11","author":"Ruiz","year":"2022","journal-title":"elife"},{"key":"2025042106064845100_ref22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archneur.1988.00520350092022","article-title":"Muscle-specific carbonic anhydrase 3 is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders","volume":"45","author":"Vaananen","year":"1988","journal-title":"Arch Neurol"},{"key":"2025042106064845100_ref23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14789450.2021.2017776","article-title":"Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle","volume":"18","author":"Dowling","year":"2021","journal-title":"Expert Rev Proteomics"},{"key":"2025042106064845100_ref24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/508500","article-title":"Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies","volume":"79","author":"Zhou","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2025042106064845100_ref25","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1172\/JCI31960","article-title":"Histone deacetylase degradation and Mef2 activation promote the formation of slow twitch myofibers","volume":"117","author":"Potthoff","year":"2007","journal-title":"J Clin Invest"},{"key":"2025042106064845100_ref26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/nar\/gkaa1203","article-title":"A comprehensive epigenome atlas reveals DMA methylation regulating skeletal muscle development","volume":"49","author":"Yang","year":"2021","journal-title":"Nucl Acid Res"},{"key":"2025042106064845100_ref27","first-page":"19","article-title":"DNA methylation dynamics in muscle development and disease","volume":"7","author":"Carrio`","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"2025042106064845100_ref28","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1152\/japplphysiol.00867.2016","article-title":"DNA methylation assessment from human fast and slow-twitch skeletal muscle fibers","volume":"122","author":"Begue","year":"2017","journal-title":"J Appl Physiol"},{"key":"2025042106064845100_ref29","doi-asserted-by":"crossref","first-page":"e106491","DOI":"10.15252\/embj.2020106491","article-title":"A necessary role of DNMT3A in endurance exercise by suppressing ALDH1L1-mediated oxidative stress","volume":"40","author":"Villivalam","year":"2021","journal-title":"EMBO J"},{"key":"2025042106064845100_ref30","doi-asserted-by":"crossref","first-page":"e1009325","DOI":"10.1371\/journal.pgen.1009325","article-title":"Ablation of DNA-methyltransferase 3A in skeletal muscle does not affect energy metabolism or exercise capacity","volume":"17","author":"Small","year":"2021","journal-title":"PLoS Genet"},{"key":"2025042106064845100_ref31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00099.2020","article-title":"Difference in potential DNA methylation impact on gene expression between fast- and slow-type myofibers","volume":"53","author":"Oe","year":"2021","journal-title":"Physiol Genomics"},{"key":"2025042106064845100_ref32","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1073\/pnas.1814263116","article-title":"Integrative analysis of gene expression, DNA methylation, physiological traits, and genetic variation in human skeletal muscle","volume":"116","author":"Taylor","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025042106064845100_ref33","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/hmg\/ddy149","article-title":"Inositol trisphosphate receptor-mediated Ca2+ signalling stimulates mitochondrial function and gene expression in core myopathy patients","volume":"27","author":"Suman","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2025042106064845100_ref34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/humu.22326","article-title":"RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling","volume":"34","author":"Zhou","year":"2013","journal-title":"Hum Mutat"},{"key":"2025042106064845100_ref35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.RES.84.6.713","article-title":"Identification and expression of d-isoforms of the multifunctional Ca2+\/Calmodulin dependent protein kinase in failing and nonfailing human myocardium","volume":"84","author":"Hoch","year":"1999","journal-title":"Circ Res"},{"key":"2025042106064845100_ref36","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.RES.0000194329.41863.89","article-title":"Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure","volume":"97","author":"Ai","year":"2025","journal-title":"Circ Res"},{"key":"2025042106064845100_ref37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M108525200","article-title":"The cardiac-specific nuclear de isoform of Ca2+\/Calmodulin-dependent protein kinase Il induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"2025042106064845100_ref38","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI38022","article-title":"Requirement for Ca2+\/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice","volume":"119","author":"Ling","year":"2009","journal-title":"J Clin Invest"},{"key":"2025042106064845100_ref39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jocn.2019.08.068","article-title":"Proteomic analysis of the skeletal muscles from dysferlinopathy patients","volume":"71","author":"Choi","year":"2020","journal-title":"J Clin Neurosci"},{"key":"2025042106064845100_ref40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-510X(83)90023-0","article-title":"Carbonic anhydrase III in neuromuscular disorders","volume":"59","author":"Heath","year":"1983","journal-title":"J Neurol Sci"},{"key":"2025042106064845100_ref41","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1074\/jbc.RA120.013846","article-title":"Bi-allelic expression of the RyR1 p.A4329D mutation decreases muscle strength in slow-twitch muscles in mice","volume":"295","author":"Elbaz","year":"2020","journal-title":"J Biol Chem"},{"key":"2025042106064845100_ref42","doi-asserted-by":"crossref","first-page":"100144","DOI":"10.1016\/j.xgen.2022.100144","article-title":"DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse","volume":"2","author":"Zhou","year":"2022","journal-title":"Cell genomics"},{"key":"2025042106064845100_ref43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","article-title":"Single-plot, solid-phase-enhanced sample preparation for proteomics experiments","volume":"14","author":"Hughes","year":"2019","journal-title":"Nat Protoc"},{"key":"2025042106064845100_ref44","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/pmic.201000722","article-title":"Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells","volume":"11","author":"Wang","year":"2011","journal-title":"Proteomics"},{"key":"2025042106064845100_ref45","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acs.jproteome.6b00066","article-title":"Evaluation and improvement of quantification accuracy in isobaric mass-tag-based protein quantification experiments","volume":"15","author":"Ahrn\u00e9","year":"2016","journal-title":"J Proteome Res"},{"key":"2025042106064845100_ref46","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/bioinformatics\/btu305","article-title":"MSstats: and R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments","volume":"30","author":"Choi","year":"2014","journal-title":"Bioinformatics"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/34\/9\/790\/61870469\/ddaf021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/34\/9\/790\/61870469\/ddaf021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T10:07:10Z","timestamp":1745230030000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/34\/9\/790\/8011499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,2,13]]},"published-print":{"date-parts":[[2025,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaf021","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,1]]},"published":{"date-parts":[[2025,2,13]]}}}